Cibus, Inc. (CBUS) Financial Statements (2025 and earlier)

Company Profile

Business Address 6455 NANCY RIDGE DRIVE
SAN DIEGO, CA 92121
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 287 - Agricultural Chemicals (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2024
Q4
9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments28,80530,02124,50732,69931,88350,895
Cash and cash equivalent28,80530,02124,50732,69931,88350,895
Receivables1,1901,058650530560858
Contract with customer, asset, after allowance for credit loss 100200200200  
Other undisclosed current assets1,4781,8201,3601,7912,0293,093
Total current assets:31,57333,09926,71735,22034,47254,846
Noncurrent Assets
Operating lease, right-of-use asset34,43235,60320,45821,68522,93522,550
Intangible assets, net (including goodwill)287,502469,392469,851470,309720,187720,645
Goodwill253,466434,898434,898434,898585,266585,266
Intangible assets, net (excluding goodwill)34,03634,49434,95335,411134,921135,379
Other noncurrent assets1,4571,5221,3511,4221,4441,238
Other undisclosed noncurrent assets12,91013,76414,65715,77517,19714,989
Total noncurrent assets:336,301520,281506,317509,191761,763759,422
TOTAL ASSETS:367,874553,380533,034544,411796,235814,268
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities10,2529,8789,9767,87411,3738,996
Accounts payable7,0236,1966,6726,1276,2813,960
Accrued liabilities3,2293,6823,3041,7475,0925,036
Deferred revenue1,0821,6231,4601,2101,6371,547
Debt4475096781,0201,4001,726
Other liabilities3711   
Other undisclosed current liabilities10,13416,9559,59711,21910,66910,176
Total current liabilities:21,91828,97221,72221,32325,07922,445
Noncurrent Liabilities
Long-term debt and lease obligation291484557649731719
Long-term debt, excluding current maturities291365441536629719
Finance lease, liability  119116113102 
Liabilities, other than long-term debt33,57934,52417,34718,89320,81820,948
Other liabilities1,7281,7001,6951,8681,9742,078
Operating lease, liability31,85132,82415,65217,02518,84418,870
Other undisclosed noncurrent liabilities191,205182,330173,581165,252157,113148,977
Total noncurrent liabilities:225,075217,338191,485184,794178,662170,644
Total liabilities:246,993246,310213,207206,117203,741193,089
Temporary equity, including noncontrolling interest12,74136,57241,61044,824129,104136,866
Equity
Equity, attributable to parent, including:108,140270,498278,217293,470463,390484,313
Treasury stock, value(1,999)(1,999)(1,912)(1,785)(1,785)(1,785)
Additional paid in capital818,210800,606783,351775,017727,821722,327
Accumulated other comprehensive income (loss)(15)(21)(17)810(2)
Accumulated deficit(708,064)(528,096)(503,213)(479,778)(262,664)(236,235)
Other undisclosed equity, attributable to parent888888
Total equity:108,140270,498278,217293,470463,390484,313
TOTAL LIABILITIES AND EQUITY:367,874553,380533,034544,411796,235814,268

Income Statement (P&L) ($ in thousands)

12/31/2024
Q4
9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
Revenues1,6678385451,103475197
Gross profit:1,6678385451,103475197
Operating expenses(202,104)(22,320)(18,998)(270,415)(26,272)(19,508)
Operating loss:(200,437)(21,482)(18,453)(269,312)(25,797)(19,311)
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
7,7061,580(369)71(876)1,320
Loss from continuing operations before equity method investments, income taxes:(192,731)(19,902)(18,822)(269,241)(26,673)(17,991)
Other undisclosed loss from continuing operations before income taxes(8,715)(8,580)(8,136)(7,971)(7,855)(2,518)
Loss from continuing operations before income taxes:(201,446)(28,482)(26,958)(277,212)(34,528)(20,509)
Income tax expense (benefit)(13)4(14)   
Other undisclosed income from continuing operations    4  
Net loss:(201,459)(28,478)(26,972)(277,208)(34,528)(20,509)
Net income attributable to noncontrolling interest21,4913,5953,53760,0948,0991,819
Net loss available to common stockholders, diluted:(179,968)(24,883)(23,435)(217,114)(26,429)(18,690)

Comprehensive Income ($ in thousands)

12/31/2024
Q4
9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
Net loss:(201,459)(28,478)(26,972)(277,208)(34,528)(20,509)
Net income attributable to redeemable noncontrolling interest21,4913,595 
Other undisclosed comprehensive income (loss)6(5)(28)(3)15(2)
Comprehensive loss:(201,453)(28,483)(27,000)(277,211)(34,513)(20,511)
Comprehensive income, net of tax, attributable to noncontrolling interest21,4913,5963,54060,0958,0961,819
Comprehensive loss, net of tax, attributable to parent:(179,962)(24,887)(23,460)(217,116)(26,417)(18,692)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: